Stay updated on Vedolizumab for aGVHD Prophylaxis in Allo-HSCT Clinical Trial

Sign up to get notified when there's something new on the Vedolizumab for aGVHD Prophylaxis in Allo-HSCT Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Vedolizumab for aGVHD Prophylaxis in Allo-HSCT Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The record history now includes Revision: v3.3.3, and the footer no longer displays HHS Vulnerability Disclosure or Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-23T08:37:30.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    22 days ago
    No Change Detected
  4. Check
    36 days ago
    Change Detected
    Summary
    New revision entry v3.3.2 appears in the record history, and the v3.2.0 entry is removed.
    Difference
    0.1%
    Check dated 2025-11-24T17:47:57.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Removed a generic government funding/operating status notice from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2025-11-17T17:22:28.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    The new screenshot shows only minor UI/layout updates to the Record History page, with no changes to study data or statuses. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-03T09:52:59.000Z thumbnail image
  7. Check
    86 days ago
    Change Detected
    Summary
    - Added a government-operating-status notice and an NIH Clinical Center update, plus a new version tag v3.2.0. - Removed the previous version tag v3.1.0.
    Difference
    11%
    Check dated 2025-10-05T14:17:35.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    Updated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.
    Difference
    0.3%
    Check dated 2025-09-28T09:43:11.000Z thumbnail image

Stay in the know with updates to Vedolizumab for aGVHD Prophylaxis in Allo-HSCT Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Vedolizumab for aGVHD Prophylaxis in Allo-HSCT Clinical Trial page.